XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
Income tax expense attributable to pretax loss from continuing operations differed from the amounts computed by applying the U.S. federal income tax rate of 21% to pretax loss from continuing operations as a result of the following:
For the Years ended December 31,
20232022
Computed “expected” tax benefit (3,074,000)21.00 %(2,722,000)21.00 %
Increase (reduction) in income taxes resulting from):
State tax, net of federal benefit— — %(1,024,900)7.95 %
Permanent items(80,500)0.55 %— — %
Stock-based compensation221,200 (1.51)%
Research and development credits(241,800)1.65 %(224,100)1.70 %
Other130,600 (0.89)%(2,000)— %
Change in valuation allowance3,044,500 (20.80)%3,973,000 (30.65)%
Total— — %— — %
Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below as of December 31:

20232022
Deferred tax assets (liabilities):
Net operating loss carryforwards
$5,799,000 $4,115,800 
Research and development credits
619,000 377,200 
Stock based compensation647,000 349,900 
Sec. 1742,027,200 1,032,700 
Other
— 172,100 
Total deferred tax assets
9,092,200 6,047,700 
Valuation Allowance
(9,092,200)(6,047,700)
Net Deferred Tax Assets
— —